Skip to content

ClinChoice Belgium

Active
Private limited companyfounded 1994active for 32 yearsSteenweg op Mechelen 455, 1950 Kraainem, Belgium961 active companies are registered at this addressKBO/BCE: BE 0452.023.661
Summary

The annual accounts of ClinChoice Belgium for financial year 2025 show a net loss of 56% of the equity at the start of that year. The 2025 annual accounts show equity of €177,888 and a net result of -€227,259. Equity remains stable across the filed financial years (±1.5% per year). Its solvency ranks better than 12% of 3,019 sector peers (NACE 86, financial year 2025). The company has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Specialist medical practice
NACE 86220Research and development on biotechnology NACE 72101
Largest company by total assets in Kraainem, Health and social work sector1 site
Size
≈ €1.6mturnover 2025, estimated
Staff
20.5 FTE
Equity
€177,888
Loss
-€227,259
Turnover estimated from the gross margin
Financial health
52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Structure
Parent
ClinChoice Srl
Holdings
1
Auditor: Bv Robrechts Lenaerts Bedrijfsrevisoren - Réviseurs d'entreprises2025 accounts filed 61 days late4 of 15 deeds summarised
Why 52raises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €227,259, the second in a row (financial year 2025)Last filed accounts filed 61 days late; 3 of the last 3 lateEquity €177,888 (6.9% of total assets)lowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 3% of its sector peers (NACE 86, small)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 32-7
equity 6.9% of total assets
Liquidity 11-11
short-term debt 90.7% · cash 8.5%
Profitability 16-20
return on assets -8.8%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024lowest value 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.4%▲ +0.1 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025 08-2025: 0.6%▲ +0.1 percentage points vs 07-2025 09-2025: 0.8%▲ +0.2 percentage points vs 08-2025 10-2025: 0.4%▼ -0.4 percentage points vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.6%▲ +0.2 percentage points vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.5%▼ -0.1 percentage points vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.6%▲ +0.1 percentage points vs 06-2026 08-2026: 0.8%▲ +0.2 percentage points vs 07-2026 09-2026: 0.9%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.8%▼ -0.1 percentage points vs 09-2026
Credit of up to €9,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity insufficient (current ratio 0.92, compared with 1.18 in 2024, below 1; short-term debt: 90.7% and cash: 8.5% of total assets), and 93.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 6% on solvency, 1% on liquidity, 5% on profitability and 2% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Loss of €227,259, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Last filed accounts filed 61 days late; 3 of the last 3 late
NBB · filings
raises risk · Equity €177,888 (6.9% of total assets)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€227,259
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 12% of 3019 sector peers (2025).
NBB · sector comparison
Position among 3019 sector peers
Solvency
better than 12%
← weakest strongest →
raises risk · 2025 accounts filed 61 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-09-2026, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
61 days late
2024
47 days late
2023
43 days late
2022
6 days early
2021
30 days late
2020
6 days late
2019
48 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 September (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Amendment of the articles · Legal-form…Name change · Board rule…

Key points

  • Caution: Result fell in 2025from -€21,530 to -€227,259 ▼ 956% View
  • Caution: Among the weakest 5% on net resultsector median €110,667 · 2,985 companies -€227,259 View
  • Caution: Latest accounts filed lateafter the legal deadline 61 days View
  • Controlled by ClinChoice Srlthe company in turn controls 1 companies parent View
  • Caution: 2 loss-making years in a rowloss financial year 2025 -€227,259 View

By topic

Financials

Financial year
2025
Total assets
€2.6m
Loss
-€227,259
Solvency
6.9%
Turnover▲ 31.1%
Net result
20182019
Go to Financials

Board & ownership

Board
1 member
Parent
ClinChoice Srl
Auditor
Bv Robrechts Lenaerts Bedrijfsrevisoren…
  • Xin KEDirector
Go to Board & ownership

Timeline

Events
41
Since
1995
Next accounts
by 31-07-2027
  1. 03-01-2025Appointment: Xin KE (director)
  2. 20-09-2024Resignation: Carlo ZERBINI (director)
  3. 12-09-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
07-03-1994
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about ClinChoice Belgium

What is the company number of ClinChoice Belgium?
0452.023.661. In Belgium the VAT number is the company number with BE in front: BE 0452.023.661.
Where is ClinChoice Belgium based?
The registered office is at Steenweg op Mechelen 455, 1950 Kraainem.Company details
What does ClinChoice Belgium do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ClinChoice Belgium?
Private limited company (BV).
When was ClinChoice Belgium founded?
On 07-03-1994.
Is ClinChoice Belgium still active?
Yes, ClinChoice Belgium is an active enterprise in the KBO register.
How many employees does ClinChoice Belgium have?
On average 20.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of ClinChoice Belgium?
€6.1m in financial year 2019, according to the filed annual accounts.
Is ClinChoice Belgium profitable?
In financial year 2025, ClinChoice Belgium made a loss of €227,259.
Where can I find the annual accounts of ClinChoice Belgium?
ClinChoice Belgium filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ClinChoice Belgium due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to ClinChoice Belgium

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.